Haematological cancer

Better survival, toxicity no worse

Article metrics

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

ORIGINAL RESEARCH PAPER

  1. 1

    Burnett, A. K. et al. Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia. J. Clin. Oncol. doi:10.1200/JCO.2012.42.2964

Download references

Rights and permissions

Reprints and Permissions

About this article